CASTOR trial update: daratumumab/bortezomib/dexamethasone is an important regimen for R/R MM

An exciting update on the CASTOR trial was presented at the American Society of Hematology (ASH) 2017 Annual Meeting and Exposition, held in Atlanta, GA. Here, Katja Weisel, MD, of University of Tbin... Author: VJHemOnc Added: 04/20/2018
Source: Oncology Tube - Category: Cancer & Oncology Source Type: podcasts